Docoh
Loading...

HUGE FSD Pharma

Innovet Italia is an innovative animal health company, founded in Italy in 1996. Its main goal is to bring scientific innovation in niche fields of the veterinary market. The philosophy that drives Innovet's development is to follow where nature leads, studying and mimicking natural protective body responses rather than 'artificially' fighting the mechanisms of diseases. Based on such a strategic idea, Innovet's research team discovered and patented a family of bioactive lipid amides (i.e., aliamides, whose parent compound is palmitoylethanolamide, PEA) able to naturally restore the physiological balance of the hyper-reactive tissues. PEA, its micronized and ultramicronized forms and various other congeners, are the main components of Innovet's innovative products. Innovet's commercial effort is mainly focused on the small animal health field, in many market segments (i.e. dermatology, orthopedics, oral health, uro-nephrology, behavior, gastroenterology, ophthalmology and algology).

Company profile

HUGE stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

16 Mar 21
21 Oct 21
31 Dec 21
Quarter (USD)
Dec 20 Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from FSD Pharma earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

41.1% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 21 23 -8.7%
Opened positions 3 22 -86.4%
Closed positions 5 0 NEW
Increased positions 7 0 NEW
Reduced positions 2 0 NEW
13F shares
Current Prev Q Change
Total value 1.91M 7.46M -74.4%
Total shares 14.8M 14.61M +1.3%
Total puts 214.4K 362.2K -40.8%
Total calls 271K 275.6K -1.7%
Total put/call ratio 0.8 1.3 -39.8%
Largest owners
Shares Value Change
Durkacz Anthony 13.7M $0 0.0%
Davy Global Fund Management 581.64K $1.01M +33.4%
Susquehanna International 326.31K $571K +7.9%
Citadel Advisors 88.04K $154K +160.6%
Rossmore Private Capital 23.04K $40K 0.0%
VIRT Virtu Financial 16.77K $29K NEW
Simplex Trading 15.91K $27K +86.4%
Raymond James & Associates 15K $26K 0.0%
Two Sigma Advisers 12.1K $21K -61.0%
Advisory Services Network 10.07K $18K 0.0%
Largest transactions
Shares Bought/sold Change
Davy Global Fund Management 581.64K +145.64K +33.4%
Citadel Advisors 88.04K +54.26K +160.6%
Penserra Capital Management 0 -27.06K EXIT
Susquehanna International 326.31K +23.85K +7.9%
Two Sigma Advisers 12.1K -18.9K -61.0%
VIRT Virtu Financial 16.77K +16.77K NEW
Jane Street 0 -16.29K EXIT
Simplex Trading 15.91K +7.38K +86.4%
BAC Bank Of America 4.4K +4.4K +440000.0%
Steward Partners Investment Advisory 0 -3K EXIT
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg

Proxies

No filings

Other

No filings